Variability in prevalence of helicobacter pylori strains resistant to clarithromycin and levofloxacin in Southern Poland

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Karczewska, Elbieta ^a   Klesiewicz, Karolina ^a   Skiba, Iwona ^a   Wojtas Bonior, Izabela ^a   Sito, Edward ^b   Czajecki, Krzysztof ^b   Zwolińska Wcisło, Małgorzata ^a   Budak, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Outpatient Clinic of Gastroenterology   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH SALT; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; PROBIOTIC AGENT; TETRACYCLINE;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; DRUG TREATMENT FAILURE; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POLAND; TREATMENT DURATION;

EID: 84862281700     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/418010     Document Type: Article

References (36)

1. Review Team, Helicobacter pylori in Developing Countries 2010 World Gastroenterology Organization
2. Zawadzka-Gralec A., Wrblewska M., Szaflarska-Popawska A., Mierzwa G., Parzecka M., Baa G., lusarska-Kopala J., Czerwionka-Szaflarska M., The drug sensitivity of Helicobacter pylori strainsour own observation Pediatria Wspolczesna 2008 10 1 29 31 (Pubitemid 351890498)
3. Marshall B. J., Warren J. R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration The Lancet 1984 1 8390 1311 1314 (Pubitemid 14111103)
4. Chey W. D., Wong B. C. Y., American College of Gastroenterology guideline on the management of Helicobacter pylori infection American Journal of Gastroenterology 2007 102 8 1808 1825 (Pubitemid 47206706)
5. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E. J., Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report Gut 2007 56 6 772 781 (Pubitemid 46854190)
6. Dzieniszewski J., Jarosz M., Bartnik W., Bak-Romaniszyn L., Bielaski W., Celiska-Cedro D., Chojnacki J., Czkwanianc E., Dabrowski A., Dzierzanowska D., Habior A., Hartleb M., Huk J., Iwaczak B., Iwaczak F., Janiak M., Kasiska E., Klapaczyski J., Klincewicz H., Klupiska G., Kotynia J., Linke K., aszewicz W., Maecka-Panas E., Marek T., Neubauer K., Owczarek D., Palka M., Przytulski K., Rozynek E., Rydzewska G., Socha J., Starzyska T., Smoczyski M., Swiatkowski M., Consensus of the Polish Society of Gastroenterology Helicobacter pylori Working Group on diagnostic and therapeutic approaches for the Helicobacter pylori infection Gastroenterologia Polska 2008 15 5 323 331
7. O'Connor A., Gisbert J. P., McNamara D., O'Morain C., Treatment of Helicobacter pylori Infection 2010 Helicobacter 2011 16 supplement 1 53 58
8. Ziemniak W., Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics Journal of Physiology and Pharmacology 2006 57 3 123 141 (Pubitemid 44641541)
9. Lind T., van Zanten S. V., Unge P., Spiller R., Bayerdrffer E., O'Morain C., Bardhan K. D., Bradette M., Chiba N., Wrangstadh M., Cederberg C., Idstrm J. P., Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study Helicobacter 1996 1 3 138 144 (Pubitemid 126671139)
10. Basu P. P., Rayapudi K., Pacana T., Shah N. J., Krishnaswamy N., Flynn M., A Randomized study comparing levofloxacin, omeprazole, nitazoxanide and doxycycline versus triple therapy for the eradication of Helicobacter pylori The American Journal of Gastroenterology 2011 106 11 1970 1975
11. Molina-Infante J., Perez-Gallardo B., Fernandez-Bermejo M., Hernandez-Alonso M., Vinagre G., Dueas C., Mateos-Rodriguez J. M., Gonzalez-Garcia G., Abadia E. G., Gisbert J. P., Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication Alimentary Pharmacology and Therapeutics 2010 31 10 1077 1084
12. Karczewska E., Wojtas I., Budak A., Wystpowanie pierwotnej opornoci Helicobacter pylori na leki przeciwbakteryjne w Polsce i na wiecie Postpy Mikrobiologii 2009 48 1 31 41
13. Karczewska E., Wojtas-Bonior I., Sito E., Zwoliska-Wciso M., Budak A., Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland Pharmacological Reports 2011 63 3 799 807
14. Abadi A. T., Taghvaei T., Mobarez A. M., Carpenter B. M., Merrell D. S., Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the Northern Population of Iran The Journal of Microbiology 2011 49 6 987 993
15. De Francesco V., Giorgio F., Ierardi E., Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) Study Journal of Gastrointestinal and Liver Diseases 2011 20 3 235 239
16. Jaime Natan E., Silva F. M., Barbuti R. C., Navarro-Rodriguez T., Moraes-Filho J. P., Pedrazzoli J. Jr., Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option Archives of Gastroenterology 2011 48 4 261 264
17. Molina-Infante J., Gisbert J. P., Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating. Gut. In press
18. Talebi Bezmin Abadi A., Ghasemzadeh A., Taghvaei T., Mobarez A. M., Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Internal and Emergency Medicine. In press
19. Malfertheiner P., Bazzoli F., Delchier J. C., Celiski K., Gigure M., Rivire M., Mégraud F., Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial The Lancet 2011 377 9769 905 913
20. Iwaczak F., Iwaczak B., Nowe moliwoci leczenia zakaenia Helicobacter pylori Przegld Gastroenterologiczny 2011 6 364 369
21. Bogaerts P., Berhin C., Nizet H., Glupczynski Y., Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium Helicobacter 2006 11 5 441 445 (Pubitemid 44352615)
22. Mégraud F., Lehn N., Lind T., Bayerdrffer E., O'Morain C., Spiller R., Unge P., Veldhuyzen Van Zanten S., Wrangstadh M., Burman C. F., Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study Antimicrobial Agents and Chemotherapy 1999 43 11 2747 2752 (Pubitemid 29519559)
23. Mégraud F., H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 2004 53 9 1374 1384 (Pubitemid 39120130)
24. Cuadrado-Lavn A., Salcines-Caviedes J. R., Carrascosa M. F., Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain Journal of Antimicrobial Chemotherapy 2012 67 1 170 173
25. Dzieranowska D., Antybiotykoterapia Praktyczna 2008 chapter 2.1 Bielsko-Biaa, Poland Alfa Medica Press
26. Jones K. R., Cha J. H., Merrell D. S., Who's winning the war? Molecular mechanisms of antibiotic resistance in Helicobacter pylori Current Drug Therapy 2008 3 3 190 203
27. Miendje Deyi V. Y., Bontems P., Vanderpas J., De Koster E., Ntounda R., Van Den Borre C., Cadranel S., Burette A., Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium Journal of Clinical Microbiology 2011 49 6 2200 2209
28. Cabrita J., Oleastro M., Matos R., Manhente A., Cabralc J., Barros R., Lopes A. I., Ramalho P., Neves B. C., Guerreiro A. S., Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (19901999) Journal of Antimicrobial Chemotherapy 2000 46 6 1029 1031 (Pubitemid 32000618)
29. Hung K. H., Sheu B. S., Chang W. L., Wu H. M., Liu C. C., Wu J. J., Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan Helicobacter 2009 14 1 61 65
30. Lin J.-T.,. Successful treatment of Helicobacter pylori infections with levofloxacin: a case report from Taiwan and a review of the literature, 2008, http://www.infectweb.com/only/artsrv20084.pdf
31. Gisbert J. P., Castro-Fernndez M., Bermejo F., Pérez-Aisa A., Ducons J., Fernndez-Bermejo M., Bory F., Cosme A., Benito L. M., Lpez-Rivas L., Lamas E., Pabn M., Olivares D., Third-line rescue therapy with levofloxacin after two H. pylori treatment failures American Journal of Gastroenterology 2006 101 2 243 247 (Pubitemid 43381662)
32. Marzio L., Coraggio D., Capodicasa S., Grossi L., Cappello G., Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole Helicobacter 2006 11 4 237 242 (Pubitemid 44051349)
33. Cianci R., Montalto M., Pandolfi F., Gasbarrini G. B., Cammarota G., Third-line rescue therapy for Helicobacter pylori infection World Journal of Gastroenterology 2006 12 15 2313 2319
34. Gatta L., Zullo A., Perna F., Ricci C., De Francesco V., Tampieri A., Bernabucci V., Cavina M., Hassan C., Ierardi E., Morini S., Vaira D., A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses Alimentary Pharmacology and Therapeutics 2005 22 1 45 49 (Pubitemid 40943874)
35. Castro-Fernndez M., Lamas E., Pérez-Pastor A., Pabn M., Aparcero R., Vargas-Romero J., Larraona J. L., Romero-Gmez M., Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori Revista Espanola de Enfermedades Digestivas 2009 101 6 399 402
36. Gisbert J. P., Pérez-Aisa A., Castro-Fernndez M., Barrio J., Rodrigo L., Cosme A., Gisbert J. L., Marcos S., Moreno-Otero R., Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin Digestive and Liver Disease 2010 42 4 287 290